Dotti Patch, Extended Release
Product Images NDC 72162-2036

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Dotti (NDC 72162-2036). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Dotti Estradiol Transdermal System 1)

Chemical structure of estradiol showing its molecular framework including hydroxyl groups, methyl group, and hydrogen atoms.*

FDA Label Image

4a (Dotti Estradiol Transdermal System 10)

An instructional illustration showing a pair of hands peeling the backing off a transdermal patch, demonstrating how to prepare the DOTTI Estradiol 0.1 mg/d extended release patch for application.*

FDA Label Image

4b (Dotti Estradiol Transdermal System 11)

An instructional line drawing showing two hands peeling apart a protective backing from a DOTTI transdermal patch for application. The image demonstrates how to separate the patch's backing to expose the adhesive side for skin placement.*

FDA Label Image

4c (Dotti Estradiol Transdermal System 12)

An illustration showing a hand applying a small circular transdermal patch to a skin area, likely demonstrating the use of a DOTTI estradiol extended release patch for transdermal administration.*

FDA Label Image

4d (Dotti Estradiol Transdermal System 13)

An instructional illustration showing hands applying a DOTTI estradiol 0.1 mg/d transdermal patch to a person's skin, demonstrating the proper placement and application technique for this extended release patch product by Bryant Ranch Prepack.*

FDA Label Image

4e (Dotti Estradiol Transdermal System 14)

An instructional illustration showing how to apply a DOTTI estradiol transdermal patch. It depicts a person using their hands to place the patch onto their skin, demonstrating proper application technique.*

FDA Label Image

4f (Dotti Estradiol Transdermal System 15)

An instructional black and white line drawing showing the application of a transdermal patch labeled DOTTI on the forearm, indicating proper placement for use.*

FDA Label Image

4g (Dotti Estradiol Transdermal System 16)

An instructional illustration showing a hand applying a small, circular transdermal patch to the lower abdominal area of a person's torso. The image visually demonstrates the placement method for a transdermal hormonal patch.*

FDA Label Image

2 (Dotti Estradiol Transdermal System 2)

An illustration showing a cross-sectional view of the DOTTI estradiol transdermal patch with labeled layers: backing, adhesive containing estradiol, and protective liner.*

FDA Label Image

Figure 1 (Dotti Estradiol Transdermal System 3)

A line graph showing estradiol concentrations (pg/mL) over time (days) for four different daily doses: 0.1 mg/day, 0.075 mg/day, 0.05 mg/day, and 0.03/5 mg/day. The graph compares concentration profiles for these dosing levels over a period of 4 days.*

FDA Label Image

2 (Dotti Estradiol Transdermal System 4)

A bar chart comparing mean reduction from baseline over 4, 8, and 12 weeks between Estradiol 0.0375 mg/day and placebo groups. The chart shows larger reductions for Estradiol at all time points with values and sample sizes labeled for each group, highlighting statistically significant differences.*

FDA Label Image

2 (Dotti Estradiol Transdermal System 5)

A line graph showing the percent change from baseline over treatment duration in weeks (26, 52, 78, 104) for different doses of Estradiol (0.1 mg/day, 0.05 mg/day, 0.0375 mg/day, 0.025 mg/day) compared to placebo. The graph tracks changes for Estradiol doses and placebo, illustrating trends over time with markers for each dose group.*

FDA Label Image

1 (Dotti Estradiol Transdermal System 6)

A line graph depicting percent change from baseline over treatment duration in weeks (26, 52, 78, 104) for various dosages of estradiol patches and placebo. The graph compares estradiol doses of 0.1 mg/day, 0.05 mg/day, 0.0375 mg/day, 0.025 mg/day, and placebo, showing statistical significance annotations (p<0.05) for differences versus placebo at multiple time points.*

FDA Label Image

1 (Dotti Estradiol Transdermal System 7)

An instructional diagram for DOTTI (estradiol transdermal system, USP) showing multiple checkbox options for days to change the patch. The options include Sun/Wed, Mon/Thu, Tue/Fri, Wed/Sat, Thu/Sun, Fri/Mon, and Sat/Tue for scheduling patch changes.*

FDA Label Image

2 (Dotti Estradiol Transdermal System 8)

An illustration showing a hand applying a small circular transdermal patch labeled DOTTI to the lower abdomen area of a person. The image depicts the proper placement of the estradiol extended-release patch on the skin for transdermal delivery.*

FDA Label Image

3 (Dotti Estradiol Transdermal System 9)

The image shows a DOTTI estradiol transdermal patch in an extended-release form with a strength of 0.1 mg per day. The patch appears rectangular with curved edges and a small tab, suitable for transdermal application. No additional text or packaging details are visible.*

FDA Label Image

Label (Lbl721622036)

DOTTI estradiol transdermal system delivers 0.1 mg/day in an 8-system package. The label includes storage instructions, warnings, and specifies transdermal use only. The product is relabeled by Bryant Ranch Prepack, Inc. and manufactured by Amneal Pharmaceuticals, LLC, with NDC 72162-2036-2.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.